Delivery Order SPE2DB20D2104-SPE2DB25FMXPG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,247.20 to AmerisourceBergen Drug Corp for the supply of Samsca 15 mg tablets (10-count units) under a firm fixed-price contract. The award, made on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $44,091.96 to AmerisourceBergen Drug Corp for the supply of Samsca 30 mg tablets (10-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026....
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Samsca 15 mg tablets (10-count packages) valued at $7,082.40 with a firm fixed price structure. The contract, which is not set-aside and was competitively awarded, requires completion by August 18, 2025, with performance to be executed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $21,247.20 to AmerisourceBergen Drug Corp for Samsca 15 mg tablets (10-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Samsca 15 mg tablets (10-count units) valued at $21,247.20 under a firm fixed-price contract type. The delivery order, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, was competitively awarded with no set-aside designation. Performance of this order will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $42,494.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on May 30, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $14,697.32 to AmerisourceBergen Drug Corp for the supply of SAMSCA 30 mg tablets (10-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $44,091.96 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of SAMSCA 30 mg tablets (10-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a non-competitive, non-set-aside award to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency has awarded a delivery order valued at $22,045.98 to AmerisourceBergen Drug Corp for the supply of SAMSCA 30 mg tablets in quantities of 10 tablets per unit. This is a firm fixed-price delivery order with no set-aside designation, issued on September 17, 2025, with an ultimate completion date of October 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,623.60 to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) on August 15, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXPGDelivery Order
The Defense Logistics Agency awarded a $21,247.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Samsca 15 mg tablets (10-count units). The contract, which is a non-set-aside competitive award, is scheduled for completion by September 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its position as a critical federal medical procurement vendor to fulfill diverse pharmaceutical supply needs across the defense and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements, with previous awards covering a broad spectrum of medications including diabetes treatments, neurological therapies, pain management pharmaceuticals, antibiotics, and specialized medical supplies. The DLA Troop Support Medical contract enables the company to supply pharmaceutical products, vaccines, syringes, vials, and related medical commodities to support military healthcare operations globally, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 8/12/25 |